May 8, 2018 / 11:13 AM / 14 days ago

BRIEF-Alnylam Reports Preclinical Data Demonstrating Central Nervous System Delivery Of RNAi Therapeutics

May 8 (Reuters) - Alnylam Pharmaceuticals Inc:

* ALNYLAM REPORTS PRECLINICAL DATA DEMONSTRATING CENTRAL NERVOUS SYSTEM (CNS) DELIVERY OF RNAI THERAPEUTICS

* ALNYLAM PHARMACEUTICALS INC - COMPANY EXPECTS FIRST CNS-TARGETED DEVELOPMENT CANDIDATE IN 2018

* ALNYLAM PHARMACEUTICALS - EXPECTS FIRST IND IN LATE 2019/EARLY 2020, AND CAPACITY FOR SUSTAINED PIPELINE OF ONE OR MORE CNS INDS PER YEAR THEREAFTER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below